Unregulated weight-loss drugs are being marketed as prizes in social media competitions, raising serious health concerns. The practice has come to light as experts warn of the dangers associated with unlicensed medications being promoted through platforms like WhatsApp and Telegram, where substances such as retatrutide are falsely advertised as “giveaways” to entice participants.
Unlicensed Drugs in Social Media Competitions
A disturbing trend has emerged on social media, where groups host competitions offering potent unlicensed medications as prizes. The Guardian has identified several WhatsApp and Telegram channels promoting these dangerous substances, particularly retatrutide—a drug not yet approved for any medical use globally. These groups often create a sense of urgency, insisting participants must act quickly to enter these giveaways.
One such advertisement from a group named BioUK Research Peptides 2 read, “Last chance to enter – 24 hours left!” This post boasted an “ultimate peptide stack,” which included retatrutide (20mg), Glow (GHK-Cu) pens aimed at skin repair, and melanotan II (a peptide claimed to enhance tanning). Each of these substances raises significant safety concerns, particularly as they lack the necessary approvals from the Medicines and Healthcare products Regulatory Agency (MHRA).
The Risks of Unregulated Substances
Experts are alarmed by the implications of these giveaways. According to UK health guidelines, many of the substances promoted as part of these competitions are classified as tightly regulated medicines rather than harmless supplements. For instance, retatrutide remains under clinical trial evaluation and cannot be legally marketed to the public. The sale of such drugs via social media platforms not only breaches existing regulations but poses severe health risks due to the absence of safety checks and medical oversight.
The promotional tactics employed by these groups are particularly alarming. Participants are often led to believe they can enter for free by simply adding friends or following certain social media accounts. However, what they are actually engaging with is a hidden market that operates outside the bounds of legal healthcare practices.
Disguised Drug Sales
Further complicating the issue, another entity—BioBlue Cosmetics—is masquerading as a fitness coaching platform while secretly selling unlicensed so-called “skinny jabs.” The site appears legitimate, featuring fitness imagery and workout plans. However, when potential customers inquire, they discover that the coaching offered is merely a euphemism for receiving unapproved weight-loss drugs.
When approached by a Guardian reporter posing as a potential customer, an administrator revealed the coded language used to describe the drugs, confirming that “Get fit with Rita” indeed referred to retatrutide, not a fitness programme. This clever ruse allows these operators to utilise payment systems designed for legitimate businesses, thereby sidestepping regulatory scrutiny.
Expert Opinions on Digital Marketing Techniques
Emily Rickard, a research fellow at the University of Bath, criticises the use of pressure tactics like countdown timers and giveaways, which she states are designed to undermine caution regarding the use of powerful, unlicensed drugs. Dr. Piotr Ozieranski from the same institution echoes this sentiment, highlighting the troubling application of digital marketing strategies to unregulated pharmaceuticals. This trend trivialises the serious nature of unlicensed medications, promoting them as simple prizes rather than medical interventions that require appropriate oversight.
Both BioUK Research Peptides 2 and BioBlue Fitness did not respond to inquiries for comments. Meanwhile, Telegram has stated that the sale of illegal medications is strictly forbidden on its platform, while Meta, the parent company of WhatsApp, reiterated its commitment to removing content that promotes the buying or selling of weight-loss products.
Why it Matters
The promotion of unlicensed weight-loss drugs through social media competitions is not merely an issue of legality; it poses significant risks to public health. As these dangerous substances become more accessible under the guise of giveaways, vulnerable individuals seeking quick fixes may unknowingly expose themselves to severe health complications. This trend highlights the urgent need for regulatory bodies to enforce existing laws and for social media platforms to take stronger measures against such harmful practices. Public awareness and education on the dangers of unregulated medications are crucial in combatting this alarming phenomenon.
